These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34679171)

  • 21. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Body Mass Index and Incident Mild Cognitive Impairment Among African American Older Adults.
    Aiken-Morgan AT; Capuano AW; Wilson RS; Barnes LL
    J Gerontol A Biol Sci Med Sci; 2024 Mar; 79(3):. PubMed ID: 37962543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body mass index and two-year change of in vivo Alzheimer's disease pathologies in cognitively normal older adults.
    Lee S; Byun MS; Yi D; Kim MJ; Jung JH; Kong N; Jung G; Ahn H; Lee JY; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY;
    Alzheimers Res Ther; 2023 Jun; 15(1):108. PubMed ID: 37312229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia.
    Guo J; Wang J; Dove A; Chen H; Yuan C; Bennett DA; Xu W
    JAMA Psychiatry; 2022 Dec; 79(12):1180-1187. PubMed ID: 36287554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.
    Betthauser TJ; Koscik RL; Jonaitis EM; Allison SL; Cody KA; Erickson CM; Rowley HA; Stone CK; Mueller KD; Clark LR; Carlsson CM; Chin NA; Asthana S; Christian BT; Johnson SC
    Brain; 2020 Jan; 143(1):320-335. PubMed ID: 31886494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults.
    Zammit AR; Yu L; Petyuk V; Schneider JA; De Jager PL; Klein HU; Bennett DA; Buchman AS
    Neurology; 2022 Mar; 98(13):e1304-e1314. PubMed ID: 35241503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study.
    Pietrzak RH; Laws SM; Lim YY; Bender SJ; Porter T; Doecke J; Ames D; Fowler C; Masters CL; Milicic L; Rainey-Smith S; Villemagne VL; Rowe CC; Martins RN; Maruff P;
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Jan; 2(1):45-52. PubMed ID: 29560886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults.
    Rodriguez-Vieitez E; Montal V; Sepulcre J; Lois C; Hanseeuw B; Vilaplana E; Schultz AP; Properzi MJ; Scott MR; Amariglio R; Papp KV; Marshall GA; Fortea J; Johnson KA; Sperling RA; Vannini P
    Mol Psychiatry; 2021 Dec; 26(12):7813-7822. PubMed ID: 34588623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults.
    Dhana K; James BD; Agarwal P; Aggarwal NT; Cherian LJ; Leurgans SE; Barnes LL; Bennett DA; Schneider JA
    J Alzheimers Dis; 2021; 83(2):683-692. PubMed ID: 34334393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

  • 33. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum.
    Kuhn E; Perrotin A; La Joie R; Touron E; Dautricourt S; Vanhoutte M; Vivien D; de La Sayette V; Chételat G;
    Neurology; 2023 Jun; 100(24):e2454-e2465. PubMed ID: 37085328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly.
    Hsu DC; Mormino EC; Schultz AP; Amariglio RE; Donovan NJ; Rentz DM; Johnson KA; Sperling RA; Marshall GA;
    J Alzheimers Dis; 2016 Jun; 53(3):1097-105. PubMed ID: 27340843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses.
    Rouch L; Virecoulon Giudici K; Cantet C; Guyonnet S; Delrieu J; Legrand P; Catheline D; Andrieu S; Weiner M; de Souto Barreto P; Vellas B;
    Am J Clin Nutr; 2022 Dec; 116(6):1492-1506. PubMed ID: 36253968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship.
    Farrell ME; Kennedy KM; Rodrigue KM; Wig G; Bischof GN; Rieck JR; Chen X; Festini SB; Devous MD; Park DC
    JAMA Neurol; 2017 Jul; 74(7):830-838. PubMed ID: 28558099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.